| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.6M | -59.6% |
| SG&A Expense | $8.3M | +8.8% |
| Operating Income | -$13.9M | +35.3% |
| Net Income | -$13.9M | +36.1% |
| EPS (Basic) | -$0.80 | +48.4% |
| EPS (Diluted) | -$0.80 | +48.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.1M | -2.2% |
| Current Assets | $41.5M | -2.4% |
| Total Assets | $42.0M | -3.0% |
| Current Liabilities | $3.2M | +80.8% |
| Stockholders' Equity | $38.8M | -6.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | +50.9% |
| Financing Cash Flow | $7.2M | — |